ISMPP Highlights
ISMPP West – A Perfect Niche for Smaller Biotech and Pharma
The first-ever ISMPP West meeting was filled with excitement and engagement for attendees from smaller biotech and pharmaceutical companies, as well as larger companies. The meeting program addressed a niche for those who work in publication teams – or are a team of one…
ISMPP Surpasses 1,600 Members – A New Milestone!
ISMPP has exceeded 1,600 members – a new milestone in record membership! With 1,602 members as of August 31, 2018, the Society experienced a 10.3% increase in its membership from one year prior when ISMPP had 1,452 members. The main drivers of this growth were…
ISMPP West 2018 – What to Expect
The ISMPP West 2018 meeting is only three months away. Planning is in full swing. The number of registrations, exhibitors, and sponsors keeps growing. Join our journey on October 11-12, 2018, at the Marriott Gaslamp Quarter in San Diego, California. It’s ISMPP’s first-ever…
Message from Our Leadership
Robert J. Matheis
ISMPP President and CEO
News and Trends
Medical Communications Agency Best Practices for Ensuring Client Confidentiality
One of the most essential responsibilities that medical communications agencies possess is the promise to maintain the confidentiality of their pharmaceutical/ biotech client partners’ information. From the clinical trial data to the strategic and tactical communication plans…
Evidence-Based Publication Planning: Mapping the Literature
A comprehensive understanding of the clinical data and scientific literature in a therapeutic area underpins publication planning. Gap analysis is one long-standing publication planning tool that can be used for this purpose, but what makes a good gap analysis?…
Encore vs. Original Presentations: Black, White, and Shades of Gray
After an “Original” abstract and its corresponding poster have been presented at a scientific or medical congress, publication professionals sometimes face challenges when preparing subsequent “Encore” presentations, and the way forward…
What Would You Do?
In our role as medical publication professionals, we may occasionally encounter situations in which it is not obvious how to ensure good publication practice. Have you ever wished you could consult the ISMPP membership for guidance when these situations arise? Here’s your opportunity!
What Would You Do? is a section of The MAP that presents case scenarios as an educational tool for medical publication professionals. The section provides a case scenario to ponder, and readers are invited to participate in a poll by selecting one of the listed solutions. Readers can also submit their thoughts on the scenario anonymously. The poll results, plus educational insights, are posted in a later issue for readers to digest.
POLL: The Authorship Order Dilemma
You are a company medical publication professional. The publication steering committee of a company-sponsored pivotal phase 3 clinical trial has selected investigators to serve as authors, but the committee and authors are having difficulty in deciding the order of authorship. During discussions, multiple authors believe that they have equal rights to the first author position based on their contributions…
ISMPP (pronounced IzMap) is the only nonprofit organization founded by medical publication professionals for medical publication professionals